Jane Street
RXII

Jane Street’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jane Street’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35,840
Closed -$50K – 4486
2015
Q1 		$50K Buy
+35,840
New +$50K ﹤0.01% 3038
2014
Q4 		– Sell
-26,318
Closed -$54K – 3560
2014
Q3 		$54K Sell
26,318
-21,085
-44% -$43.3K ﹤0.01% 2415
2014
Q2 		$145K Buy
47,403
+15,893
+50% +$48.6K ﹤0.01% 2292
2014
Q1 		$79K Sell
31,510
-47,503
-60% -$119K ﹤0.01% 2546
2013
Q4 		$392K Buy
79,013
+43,351
+122% +$215K 0.01% 1424
2013
Q3 		$81K Sell
35,662
-9,128
-20% -$20.7K ﹤0.01% 2568
2013
Q2 		$99K Buy
+44,790
New +$99K ﹤0.01% 2441

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return